An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321

affy—analysis of Affymetrix GeneChip data at the probe level

Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,831

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Paik, S., Tang, G., Shak, S., Kim, C., Baker, J. B., Kim, W., Cronin, M. T., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,597

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Harris, L. N., Fritsche, H. A., Mennel, R. G., Norton, L., Ravdin, P. M., Taube, S. E., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,234

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050

Genes that mediate breast cancer metastasis to the brain

Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863

CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survival

Thomas, J. K., Mir, H., Kapur, N., Bae, S., & Singh, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40514-9 · Cited by 75

lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer

Zhang, Y., Li, Z., Chen, M., Chen, H., Zhong, Q., Liang, L., & Li, B. (2020) · Breast Cancer · doi:10.1007/s12282-020-01048-5 · Cited by 74

Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase

Fiorillo, M., Scatena, C., Naccarato, A. G., Sotgia, F., & Lisanti, M. P. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00788-x · Cited by 82

TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer

Xu, J., Yang, X., Deng, Q., Yang, C., Wang, D., Jiang, G., Yao, X., He, X., Ding, J., Qiang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24703-7 · Cited by 74

The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells

Zhang, S., You, X.-H., Zheng, Y., Shen, Y., Xiong, X., & Sun, Y. (2022) · Journal of Clinical Investigation · doi:10.1172/jci162434 · Cited by 76

Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer

Liu, B., Wang, T., Wang, H., Zhang, L., Xu, F., Fang, R., Li, L., Cai, X., Wu, Y., Zhang, W., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0577-5 · Cited by 73

Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer

Bouchal, P., Dvořáková, M., Roumeliotis, T. I., Bortlíček, Z., Ihnatová, I., Procházková, I., Ho, J. T. C., Maryáš, J., Imrichová, H., Budínská, E., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.041335 · Cited by 73

Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase

Han, J., Lim, W., You, D., Jeong, Y., Kim, S., Lee, J. E., Shin, T. H., Lee, G., & Park, S. (2019) · Journal of Oncology · doi:10.1155/2019/1345026 · Cited by 74

Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis

Heo, J., Noh, B., Lee, S., Lee, H., Kim, Y., Lim, J., Ju, H., Yu, H. Y., Ryu, C., Lee, P. C., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910880 · Cited by 70

Adversarial deconfounding autoencoder for learning robust gene expression embeddings

Dincer, A. B., Janizek, J. D., & Lee, S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa796 · Cited by 71

Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response

Rupp, T., Genest, L., Babin, D., Legrand, C., Hunault, M., Froget, G., & Castagné, V. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101405 · Cited by 75

SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis

Ozturk, S., Papageorgis, P., Wong, C. K., Lambert, A. W., Abdolmaleky, H. M., Thiagalingam, A., Cohen, H. T., & Thiagalingam, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514663113 · Cited by 74

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis

Lee, S., Park, K.-K., Kim, H., Park, J., Son, S. H., Kim, K., & Chung, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-09040-4 · Cited by 72

miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer

Liu, S., Wang, Z., Liu, Z., Shi, S., Zhang, Z., Zhang, J., & Lin, H. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy041 · Cited by 72

Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics

Lee, A. J. X., & Swanton, C. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.008 · Cited by 70

Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide–αVβ5 axis

Cao, Q., Chen, X., Wu, X., Liao, R., Huang, P., Tan, Y., Wang, L., Ren, G., Huang, J., & Dong, C. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172048 · Cited by 73

Single-cell RNA-sequencing of migratory breast cancer cells: discovering genes associated with cancer metastasis

Chen, Y., Sahoo, S., Brien, R., Jung, S., Humphries, B. A., Lee, W., Cheng, Y.-H., Zhang, Z., Luker, K. E., Wicha, M. S., et al. (2019) · The Analyst · doi:10.1039/c9an01358j · Cited by 71

m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer

Petri, B. J., & Klinge, C. M. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0110 · Cited by 78

Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer

Choi, H., Joo, H.-S., Won, H., Min, K., Kim, H.-Y., Son, T., Oh, Y., Lee, J., & Kong, G. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx207 · Cited by 71

USP51 promotes deubiquitination and stabilization of ZEB1.

Zhou, Z., Zhang, P., Hu, X., Kim, J., Yao, F., Xiao, Z., Zeng, L., Chang, L., Sun, Y., & Ma, L. (2017) · PubMed Central · Cited by 71

ORAI1 and ORAI3 in Breast Cancer Molecular Subtypes and the Identification of ORAI3 as a Hypoxia Sensitive Gene and a Regulator of Hypoxia Responses

Azimi, I., Milevskiy, M. J. G., Chalmers, S. B., Yapa, K. T. D. S., Robitaille, M., Henry, C., Baillie, G. J., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2019) · Cancers · doi:10.3390/cancers11020208 · Cited by 72

Protrudin-mediated ER–endosome contact sites promote MT1-MMP exocytosis and cell invasion

Pedersen, N. M., Wenzel, E. M., Wang, L., Antoine‐Bally, S., Chavrier, P., Stenmark, H., & Raiborg, C. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202003063 · Cited by 67

YAP 1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN

Guo, L., Chen, Y., Luo, J. P., Zheng, J., & Shao, G. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12597 · Cited by 70

Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors

Cancemi, P., Buttacavoli, M., Roz, E., & Feo, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163952 · Cited by 74

Capsule Network Based Modeling of Multi-omics Data for Discovery of Breast Cancer-Related Genes

Chen, P., Zheng, Y., & Huang, D.-S. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2909905 · Cited by 70

DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer

Shen, N., Korm, S., Karantanos, T., Li, D., Zhang, X., Ritou, E., Xu, H., Lam, A., English, J., Zong, W., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02805-8 · Cited by 72

Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer

Ahn, S., Park, J. H., Grimm, S. L., Piyarathna, D. W. B., Samanta, T., Putluri, V., Mezquita, D., Fuqua, S. A. W., Putluri, N., Coarfa, C., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0184 · Cited by 71

The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers

Vinnedge, L. M. P., Benight, N. M., Wagh, P. K., Pease, N. A., Nashu, M. A., Serrano‐López, J., Adams, A. K., Cancelas, J. A., Waltz, S. E., & Wells, S. I. (2014) · Oncogene · doi:10.1038/onc.2014.173 · Cited by 71

FHIT Suppresses Epithelial-Mesenchymal Transition (EMT) and Metastasis in Lung Cancer through Modulation of MicroRNAs

Suh, S.-S., Yoo, J. Y., Cui, R., Kaur, B., Huebner, K., Lee, T., Aqeilan, R. I., & Croce, C. M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004652 · Cited by 71

A CREB3-regulated ER–Golgi trafficking signature promotes metastatic progression in breast cancer

Howley, B. V., Link, L. A., Grelet, S., El-Sabban, M., & Howe, P. H. (2017) · Oncogene · doi:10.1038/s41388-017-0023-0 · Cited by 69

Long-range regulators of the lncRNAHOTAIRenhance its prognostic potential in breast cancer

Milevskiy, M. J. G., Al‐Ejeh, F., Saunus, J. M., Northwood, K. S., Bailey, P. J., Betts, J. A., Reed, A. E. M., Nephew, K. P., Stone, A. M., Gee, J. M. W., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw177 · Cited by 70

Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer

Acharya, S., Yao, J., Li, P., Zhang, C., Lowery, F. J., Zhang, Q., Guo, H., Qu, J., Yang, F., Wistuba, I. I., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3803 · Cited by 70

EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer

Ring, A., Kaur, P., & Lang, J. E. (2020) · BMC Cancer · doi:10.1186/s12885-020-07573-y · Cited by 75

ERK / MAPK regulates ERR γ expression, transcriptional activity and receptor‐mediated tamoxifen resistance in ER + breast cancer

Heckler, M. M., Thakor, H., Schafer, C. C., & Riggins, R. B. (2014) · FEBS Journal · doi:10.1111/febs.12797 · Cited by 69

Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer

Carr, A. C., Khaled, A. S., Bassiouni, R., Flores, O., Nierenberg, D., Bhatti, H. A., Vishnubhotla, P., Perez, J. M., Santra, S., & Khaled, A. R. (2017) · Oncotarget · doi:10.18632/oncotarget.22681 · Cited by 67

Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry

Jenkins, B. D., Martini, R. N., Hire, R. R., Brown, A. M., Bennett, B., Brown, I., Howerth, E. W., Egan, M., Hodgson, J., Yates, C. C., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0955 · Cited by 69

Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer

Pradhan, N., Parbin, S., Kar, S., Das, L., Kirtana, R., Seshadri, G. S., Sengupta, D., Deb, M., Kausar, C., & Patra, S. K. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.002 · Cited by 69

Single-cell RNA-sequencing reveals distinct patterns of cell state heterogeneity in mouse models of breast cancer

Yeo, S. K., Zhu, X., Okamoto, T., Hao, M., Wang, C., Lu, P., Lu, L. J., & Guan, J. (2020) · eLife · doi:10.7554/elife.58810 · Cited by 67

Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancersPreprint

Takai, K., Drain, A. P., Lawson, D. A., Littlepage, L. E., Karpuj, M. V., Kessenbrock, K., Le, A. M., Inoue, K., Weaver, V. M., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.301366.117 · Cited by 69

Identification of a claudin‐4 and E‐cadherin score to predict prognosis in breast cancer

Szász, A. M., Németh, Z., Győrffy, B., Micsinai, M., Krenács, T., Baranyai, Z., Harsányi, L., Kiss, A., Schaff, Z., Tõkés, A., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02085.x · Cited by 67

A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7

Hopkins, B., Nadler, M. J. S., Skoko, J., Bertomeu, T., Pelosi, A., Mousavi-Shafaei, P., Levine, K. M., Schempf, A. M., Pennarun, B., Yang, B., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6871 · Cited by 67

Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer

Mishra, R. R., Belder, N., Ansari, S. A., Kayhan, M., Bal, H., Raza, U., Ersan, P. G., Tokat, Ü. M., Eyüpoğlu, E., Saatci, Ö., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2776 · Cited by 68

Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells

Hapach, L. A., Carey, S. P., Schwager, S. C., Taufalele, P., Wang, W., Mosier, J. A., Ortiz-Otero, N., McArdle, T. J., Goldblatt, Z. E., Lampi, M. C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1799 · Cited by 70

The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?

de Cárcer, G. (2019) · Genes · doi:10.3390/genes10030208 · Cited by 70

SORLA regulates endosomal trafficking and oncogenic fitness of HER2

Pietilä, M., Sahgal, P., Peuhu, E., Jäntti, N. Z., Paatero, I., Närvä, E., Al-Akhrass, H., Lilja, J., Georgiadou, M., Andersen, O. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10275-0 · Cited by 75

Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway

Xu, T., Zhang, R., Dong, M., Zhang, Z., Li, H., Zhan, C., & Li, X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s222967 · Cited by 67

JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer

Chen, B., Lai, J., Dai, D., Chen, R., Li, X., & Liao, N. (2019) · Aging · doi:10.18632/aging.102514 · Cited by 69

TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer

Azuma, K., Ikeda, K., Suzuki, T., Aogi, K., Horie‐Inoue, K., & Inoue, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100784118 · Cited by 67

Oncogene-mediated metabolic gene signature predicts breast cancer outcome

Aslan, M., Hsu, E., Garcia-Marques, F. J., Bermudez, A., Liu, S., Shen, M., West, M., Zhang, C. A., Rice, M. A., Brooks, J. D., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00341-6 · Cited by 68

Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion

Cyr-Depauw, C., Northey, J. J., Tabariès, S., Annis, M. G., Dong, Z., Cory, S. M., Hallett, M. T., Rennhack, J. P., Andrechek, E. R., & Siegel, P. M. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00600-15 · Cited by 67

The calcium pump plasma membrane Ca2+-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin

Peters, A. A., Milevskiy, M. J. G., Lee, W. C., Curry, M., Smart, C. E., Saunus, J. M., Reid, L., Silva, L. M. D., Marcial, D. L., Dray, E. V., et al. (2016) · Scientific Reports · doi:10.1038/srep25505 · Cited by 67

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

Corominas-Faja, B., Vellón, L., Cuyàs, E., Buxó, M., Martı́n-Castillo, B., Serra, D., García, J., Lupu, R., & Menéndez, J. A. (2017) · PubMed · doi:10.14670/hh-11-830 · Cited by 67

MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial–mesenchymal transition, decreased ERα expression and AKT activation

Liang, Y., Zeng, D., Xiao, Y., Wu, Y., Ouyang, Y.-X., Chen, M., Li, Y., Lin, H., Wei, X., Zhang, Y., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.004 · Cited by 67

Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers

Olsen, S. N., Wronski, A., Castaño, Z., Dake, B. T., Malone, C. F., Raedt, T. D., Enos, M., DeRose, Y. S., Zhou, W., Guerra, S. L., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0520 · Cited by 67

Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer

Heilmann, K., Tóth, R., Bossmann, C., Klimo, K., Plass, C., & Gerhäuser, C. (2017) · Oncogene · doi:10.1038/onc.2017.246 · Cited by 69

Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer

Liu, M., Liu, Y., Deng, L., Wang, D., He, X., Zhou, L., Wicha, M. S., Bai, F., & Liu, S. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0809-x · Cited by 67

ITGAV targeting as a therapeutic approach for treatment of metastatic breast cancer.

Cheuk, I., Siu, M. T., Ho, J. C.-W., Chen, J., Shin, V. Y., & Kwong, A. (2020) · PubMed Central · Cited by 65

WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance

Zheng, H., Shao, F., Martin, S., Xu, X., & Deng, C. (2017) · Scientific Reports · doi:10.1038/srep43517 · Cited by 66

Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer

Muliaditan, T., Opzoomer, J. W., Caron, J., Okesola, M., Kosti, P., Lall, S. K., Hemelrijck, M. V., Dazzi, F., Tutt, A. N. J., Grigoriadis, A. E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2587 · Cited by 67

Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer

Lou, W., Liu, J., Ding, B., Jin, L., Xu, L., Li, X., Chen, J., & Fan, W. (2019) · Aging · doi:10.18632/aging.101934 · Cited by 67

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

Noblejas‐López, M. D. M., Nieto‐Jiménez, C., Morcillo-García, S., Pérez‐Peña, J., Nuncia‐Cantarero, M., Pretel, F. A., Galán‐Moya, E. M., Amir, E., Pandiella, A., Győrffy, B., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1629780 · Cited by 67

Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma

Deng, R., Huang, J.-H., Wang, Y., Zhou, L.-H., Wang, Z., Hu, B., Chen, Y., Yang, D., Mai, J., Li, Z., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01236-z · Cited by 66

Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation

Sofi, S., Jan, N., Qayoom, H., Alkhanani, M., Almilaibary, A., & Mir, M. A. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103774 · Cited by 68

IGF-I Regulates Redox Status in Breast Cancer Cells by Activating the Amino Acid Transport Molecule xC−

Yang, Y., & Yee, D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1803 · Cited by 68

Application of microarray in breast cancer: An overview

Kumar, R., Sharma, A., & Tiwari, R. (2012) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.92726 · Cited by 65

FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells

Maachani, U. B., Shankavaram, U. T., Kramp, T. R., Tofilon, P. J., Camphausen, K. A., & Tandle, A. T. (2016) · Oncotarget · doi:10.18632/oncotarget.12670 · Cited by 66

Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasisin vivo; therapeutic and chemopreventive applications

Mahmood, N., Cheishvili, D., Arakelian, A., Tanvir, I., Khan, H. A., Pépin, A.-S., Moshe Szyf, A., & Rabbani, S. A. (2017) · Oncotarget · doi:10.18632/oncotarget.23704 · Cited by 66

Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling

González-González, A., Muñoz‐Muela, E., Marchal, J. A., Cara, F. E., Molina, M. P., Cruz-Lozano, M., Jiménez, G., Verma, A., Ramírez, A., Qian, W. P., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3125 · Cited by 66

Arginine Citrullination at the C-Terminal Domain Controls RNA Polymerase II Transcription

Sharma, P., Lioutas, A., Fernández‐Fuentes, N., Quilez, J., Carbonell‐Caballero, J., Wright, R. H. G., Vona, C. D., Dily, F. L., Schüller, R., Eick, D., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.016 · Cited by 66

IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15‐Dependent BMI1 Stability

Zhang, L., Qiang, J., Yang, X., Wang, D., Rehman, A. U., He, X., Chen, W., Sheng, D., Zhou, L., Jiang, Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201901728 · Cited by 66

MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets

Antonov, A. V., Knight, R. A., Melino, G., Barlev, N. A., & Tsvetkov, P. O. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.137 · Cited by 65

p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells

Nagano, H., Hashimoto, N., Nakayama, A., Suzuki, S., Miyabayashi, Y., Yamato, A., Higuchi, S., Fujimoto, M., Sakuma, I., Beppu, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804243115 · Cited by 66

Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell–Mediated Tumor Killing

Fan, J.-B., Miyauchi, S., Xu, H., Liu, D., Kim, L. J. Y., Burkart, C., Cheng, H., Arimoto, K., Yan, M., Zhou, Y., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0608 · Cited by 63

Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis

Mishra, R., Thorat, D., Soundararajan, G., Pradhan, S. J., Chakraborty, G., Lohite, K., Karnik, S. V., & Kundu, G. C. (2014) · Oncogene · doi:10.1038/onc.2014.79 · Cited by 65

Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis

Jin, L., Zhang, Y., Li, H., Yao, L., Fu, D., Yao, X., Xu, L. X., Hu, X., & Hu, G. (2012) · Cell Research · doi:10.1038/cr.2012.90 · Cited by 65

Extracellular Matrix–receptor Interaction Signaling Genes Associated with Inferior Breast Cancer Survival

Yeh, M.-H., TZENG, Y.-J., Fu, T., You, J.-J., Chang, H., Ger, L., & Tsai, K. (2018) · Anticancer Research · doi:10.21873/anticanres.12764 · Cited by 65

Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer

Rutkovsky, A. C., Yeh, E. S., Guest, S. T., Findlay, V. J., Muise‐Helmericks, R. C., Armeson, K. E., & Ethier, S. P. (2019) · BMC Cancer · doi:10.1186/s12885-019-5667-4 · Cited by 65

SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor

Chiang, C., Pan, C., Chang, H., Lai, M.-D., Tzai, T., Tsai, Y., Ling, P., Liu, H., Lee, B., Cheng, H.-L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3308 · Cited by 64

Prognostic values of E2F mRNA expression in human gastric cancer

Manicum, T., Ni, F., Ye, Y., Fan, X., & Chen, B. (2018) · Bioscience Reports · doi:10.1042/bsr20181264 · Cited by 64

Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression

Yan, J., Jia, Y., Chen, H., Chen, W., & Zhou, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1379-5 · Cited by 64

Human CST complex protects stalled replication forks by directly blocking MRE11 degradation of nascent‐strand DNA

Lyu, X., Lei, K.-H., Sang, P. B., Shiva, O., Chastain, M., Chi, P., & Chai, W.-H. (2020) · EMBO Journal · doi:10.15252/embj.2019103654 · Cited by 54

An explainable AI-driven biomarker discovery framework for Non-Small Cell Lung Cancer classification

Dwivedi, K., Rajpal, A., Rajpal, S., Agarwal, M., Kumar, V., & Kumar, N., V (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106544 · Cited by 70

Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1

Grek, C. L., Rhett, J. M., Bruce, J. S., Abt, M. A., Ghatnekar, G. S., & Yeh, E. S. (2015) · BMC Cancer · doi:10.1186/s12885-015-1229-6 · Cited by 64

The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers

Légaré, S., Cavallone, L., Mamo, A., Chabot, C., Sirois, I., Magliocco, A. M., Klimowicz, A. C., Tonin, P. N., Buchanan, M., Keilty, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3475 · Cited by 64

Phosphorylation of calcium/calmodulin-stimulated protein kinase II at T286 enhances invasion and migration of human breast cancer cells

Chi, M., Evans, H. M., Gilchrist, J., Mayhew, J., Hoffman, A., Pearsall, E., Jankowski, H., Brzozowski, J. S., & Skelding, K. A. (2016) · Scientific Reports · doi:10.1038/srep33132 · Cited by 64

Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer

Duhachek-Muggy, S., Qi, Y., Wise, R., Alyahya, L., Li, H. Z., Hodge, J., & Żółkiewska, A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0599-6 · Cited by 64

Cancer-Associated Intermediate Conductance Ca2+-Activated K+ Channel KCa3.1

Mohr, C. J., Steudel, F. A., Gross, D., Ruth, P., Lo, W., Hoppe, R., Schroth, W., Brauch, H. B., Huber, S. M., & Łukowski, R. (2019) · Cancers · doi:10.3390/cancers11010109 · Cited by 64

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancerin vivo

Bolli, E., O’Rourke, J. P., Conti, L., Lanzardo, S., Rolih, V., Christen, J. M., Barutello, G., Forni, M., Pericle, F., & Cavallo, F. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1408746 · Cited by 66

SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells

Wang, C., Zhou, Z., Subhramanyam, C. S., Cao, Q., Heng, Z. S., Liu, W., Fu, X., & Hu, Q. (2020) · Communications Biology · doi:10.1038/s42003-020-0983-4 · Cited by 64

Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells

Koufaris, C., Valbuena, G. N., Pomyen, Y., Tredwell, G. D., Nevedomskaya, E., Lau, C.-H., Yang, T.-Y., Benito, A., Ellis, J. K., & Keun, H. C. (2015) · Oncogene · doi:10.1038/onc.2015.333 · Cited by 64

Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability

Powell, C. A., Nasser, M. W., Zhao, H., Wochna, J. C., Zhang, X., Shapiro, C. L., Shilo, K., & Ganju, R. K. (2015) · Oncotarget · doi:10.18632/oncotarget.3442 · Cited by 63

CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid‐specific cancer cell death through autophagy induction

Lee, A. J. X., Roylance, R. R., Sander, J., Gorman, P. A., Endesfelder, D., Kschischo, M., Jones, N. P., East, P., Nicke, B., Spassieva, S. D., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2998 · Cited by 65

ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype

Junankar, S. R., Baker, L. A., Roden, D. L., Nair, R., Elsworth, B., Gallego‐Ortega, D., Lacaze, P. A., Cazet, A., Nikolić, I., Teo, W. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7548 · Cited by 62

ATIP3, a Novel Prognostic Marker of Breast Cancer Patient Survival, Limits Cancer Cell Migration and Slows Metastatic Progression by Regulating Microtubule Dynamics

Molina, A., Vélot, L., Ghouinem, L., Abdelkarim, M., Bouchet, B. P., Luissint, A., Bouhlel, I. B., Morel, M., Sapharikas, E., Tommaso, A. D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3565 · Cited by 66

Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells

Lambert, A. W., Wong, C. K., Ozturk, S., Papageorgis, P., Raghunathan, R., Alekseyev, Y. O., Gower, A. C., Reinhard, B. M., Abdolmaleky, H. M., & Thiagalingam, S. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0079 · Cited by 63

Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers

Ward, A. K. K., Mellor, P., Smith, S., Kendall, S., Just, N., Vizeacoumar, F. S., Sarker, S., Phillips, Z., Alvi, R., Saxena, A., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0672-x · Cited by 63

Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism

Debeb, B. G., Lacerda, L., Larson, R. A., Wolfe, A. R., Krishnamurthy, S., Reuben, J. M., Ueno, N. T., Gilcrease, M. Z., & Woodward, W. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8631 · Cited by 62

Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer

Légaré, S., & Basik, M. (2016) · Molecular Endocrinology · doi:10.1210/me.2016-1072 · Cited by 63

CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer

Dai, M., Zhang, C., Ali, A., Hong, X., Tian, J., Lo, C., Fils-Aimé, N., Burgos, S. A., Ali, S., & Lebrun, J. J. (2016) · Scientific Reports · doi:10.1038/srep35383 · Cited by 65

P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-p1-07-18 · Cited by 70

Online biomarker validation of survival-associated biomarkers in breast and ovarian cancer using microarray data of 3,862 patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.10571

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 2,024

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

van Laar, R. K. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.003 · Cited by 12

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Jézéquel, P., Campone, M., Gouraud, W., Guérin‐Charbonnel, C., Leux, C., Ricolleau, G., & Campion, L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1457-7 · Cited by 410